Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1979 1
1984 1
1985 1
1988 1
1990 3
1994 1
1996 3
1999 3
2000 1
2001 2
2005 2
2006 5
2010 4
2011 1
2013 2
2014 1
2019 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Childhood brainstem astrocytoma"
Page 1
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
BACKGROUND: Paediatric low-grade glioma is the most common CNS tumour of childhood. Although overall survival is good, disease often recurs. ...This trial is registered with ClinicalTrials.gov, number NCT01089101. ...
BACKGROUND: Paediatric low-grade glioma is the most common CNS tumour of childhood. Although overall survival is good, disease often …
STAT3 as a Therapeutic Target for Glioblastoma.
Liu Y, Li C, Lin J. Liu Y, et al. Anticancer Agents Med Chem. 2010 Sep;10(7):512-9. doi: 10.2174/187152010793498636. Anticancer Agents Med Chem. 2010. PMID: 20879983 Review.
Glioblastoma (GBM) is the most common type of primary malignant brain tumor. Despite advances in surgical resection, radiotherapy and chemotherapy, prognosis remains very poor. ...Here we focused on the recent progresses regarding to the roles of STAT3 in glioblastoma and …
Glioblastoma (GBM) is the most common type of primary malignant brain tumor. Despite advances in surgical resection, radiotherapy and …
Astrocytoma in childhood: survival and performance.
Mandigers CM, Lippens RJ, Hoogenhout J, Meijer E, von Wieringen PM, Theeuwes AG. Mandigers CM, et al. Pediatr Hematol Oncol. 1990;7(2):121-8. doi: 10.3109/08880019009033381. Pediatr Hematol Oncol. 1990. PMID: 1698433
Seventy-nine children (35 female, 44 male) with proven or presumed astrocytoma were treated from 1967 to 1987. The tumors were supratentorial located in 24 children, cerebellar in 21 children, and pontine in 34 children. ...Low-graded tumors (46%) were irradiated with a lo …
Seventy-nine children (35 female, 44 male) with proven or presumed astrocytoma were treated from 1967 to 1987. The tumors were suprat …
Treatments for astrocytic tumors in children: current and emerging strategies.
Burzynski SR. Burzynski SR. Paediatr Drugs. 2006;8(3):167-78. doi: 10.2165/00148581-200608030-00003. Paediatr Drugs. 2006. PMID: 16774296 Review.
Strategies for the treatment of childhood cancer have changed considerably during the last 50 years and have led to dramatic improvements in long-term survival. ...Astrocytic tumors form the most common histologic group among childhood brain tumors. They are …
Strategies for the treatment of childhood cancer have changed considerably during the last 50 years and have led to dramatic improvem …
Pathology, treatment and management of posterior fossa brain tumors in childhood.
Bonner K, Siegel KR. Bonner K, et al. J Neurosci Nurs. 1988 Apr;20(2):84-93. doi: 10.1097/01376517-198804000-00004. J Neurosci Nurs. 1988. PMID: 2966218 Review.
These included primitive neuroectodermal tumor (n = 86, 19%), astrocytoma (n = 135, 30%), brainstem glioma (n = 47, 10%), anaplastic astrocytoma (n = 32, 7%), and ependymoma (n = 30, 6%). ...This article addresses incidence, classification and histology, c …
These included primitive neuroectodermal tumor (n = 86, 19%), astrocytoma (n = 135, 30%), brainstem glioma (n = 47, 10%), anap …
The impact of extent of resection in the management of malignant gliomas of childhood.
Finlay JL, Wisoff JH. Finlay JL, et al. Childs Nerv Syst. 1999 Nov;15(11-12):786-8. doi: 10.1007/s003810050471. Childs Nerv Syst. 1999. PMID: 10603023 Review.
Radical surgical resection of newly diagnosed glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) in children is the most powerful favorable predictor of outcome when followed by radiation therapy and chemotherapy. In the largest study of childhood maligna …
Radical surgical resection of newly diagnosed glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) in children is the most p …
Postoperative speech impairment and surgical approach to posterior fossa tumours in children: a prospective European multicentre cohort study.
Grønbæk JK, Wibroe M, Toescu S, Frič R, Thomsen BL, Møller LN, Grillner P, Gustavsson B, Mallucci C, Aquilina K, Fellows GA, Molinari E, Hjort MA, Westerholm-Ormio M, Kiudeliene R, Mudra K, Hauser P, van Baarsen K, Hoving E, Zipfel J, Nysom K, Schmiegelow K, Sehested A, Juhler M, Mathiasen R; CMS study group. Grønbæk JK, et al. Lancet Child Adolesc Health. 2021 Nov;5(11):814-824. doi: 10.1016/S2352-4642(21)00274-1. Epub 2021 Oct 6. Lancet Child Adolesc Health. 2021. PMID: 34624241
BACKGROUND: Brain tumours are the most common solid tumours in childhood. Half of these tumours occur in the posterior fossa, where surgical removal is complicated by the risk of cerebellar mutism syndrome, of which postoperative speech impairment (POSI) is a cardin …
BACKGROUND: Brain tumours are the most common solid tumours in childhood. Half of these tumours occur in the posterior fossa, …
Diffuse and focal brain stem tumors in childhood: prognostic factors and surgical outcome. Experience in a single institution.
Sandri A, Sardi N, Genitori L, Giordano F, Peretta P, Basso ME, Bertin D, Mastrodicasa L, Todisco L, Mussa F, Forni M, Ricardi U, Cordero di Montezemolo L, Madon E. Sandri A, et al. Childs Nerv Syst. 2006 Sep;22(9):1127-35. doi: 10.1007/s00381-006-0083-x. Epub 2006 Mar 28. Childs Nerv Syst. 2006. PMID: 16568342
OBJECTIVE: Brainstem tumors (BSTs) are usually gliomas and are divided into diffuse BSTs (DBSTs) and focal BSTs (FBSTs). ...
OBJECTIVE: Brainstem tumors (BSTs) are usually gliomas and are divided into diffuse BSTs (DBSTs) and focal BSTs (FBSTs). ...
Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma.
Massimino M, Biassoni V. Massimino M, et al. Expert Rev Anticancer Ther. 2006 May;6(5):709-17. doi: 10.1586/14737140.6.5.709. Expert Rev Anticancer Ther. 2006. PMID: 16759162 Review.
Brain tumors are the second most common cancer in pediatric patients and the main cause from death of malignant tumors in this age group. High-grade or malignant glioma, among which anaplastic astrocytomas and glioblastoma are the most prevalent histotypes, represen …
Brain tumors are the second most common cancer in pediatric patients and the main cause from death of malignant tumors in this age gr …
ACTH deficiency in childhood cancer survivors.
Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM. Rose SR, et al. Pediatr Blood Cancer. 2005 Nov;45(6):808-13. doi: 10.1002/pbc.20327. Pediatr Blood Cancer. 2005. PMID: 15700255
BACKGROUND: Adrenocorticotropin deficiency (ACTHD) can be clinically subtle, but life-threatening if not recognized. We assessed the prevalence of ACTHD in survivors of childhood cancer according to tumor diagnosis/therapy. PROCEDURE: Chart review of endocrine/oncology his …
BACKGROUND: Adrenocorticotropin deficiency (ACTHD) can be clinically subtle, but life-threatening if not recognized. We assessed the prevale …
36 results